Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck 2019 Restructuring Program (legacy) by Quarter
2019 Restructuring Program (legacy) — Recorded in R&D ($M) ($M)
Merck 2019 Restructuring Program (legacy): $0M in Q4 2023. No newer figure appears in the documents we track.
Where the Q4 2023 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-Q / 10-K Restructuring Footnote.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 2019 Restructuring Program (legacy) — Recorded in R&D ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2023 | Dec 31, 2023 | 0 | – | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2023 | Sep 30, 2023 | 0 | – | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2023 | Jun 30, 2023 | 1 | – | Form 10-Q (filed 2024-08-05) ↗ |
Cite this data
StockData. (2026). Merck 2019 Restructuring Program (legacy) ($M), quarterly Q2 2023–Q4 2023 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/restr-program2019-line-rd
See every metric in the Merck KPI table. Data updated Oct 26, 2026.